Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 854 JPY 1.19% Market Closed
Market Cap: ¥435.2B

P/E

119
Current
260%
More Expensive
vs 3-y average of 33

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
119
=
Market Cap
¥440.5B
/
Net Income
¥3.7B

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
119
=
Market Cap
¥440.5B
/
Net Income
¥3.7B

Valuation Scenarios

Kobayashi Pharmaceutical Co Ltd is trading above its 3-year average

If P/E returns to its 3-Year Average (33), the stock would be worth ¥1 624.78 (72% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-86%
Maximum Upside
No Upside Scenarios
Average Downside
79%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple 119 ¥5 854
0%
3-Year Average 33 ¥1 624.78
-72%
5-Year Average 34.4 ¥1 693.91
-71%
Industry Average 17.1 ¥841.65
-86%
Country Average 17 ¥836.6
-86%

Forward P/E
Today’s price vs future net income

Today's Market Cap Net Income Forward P/E
¥440.5B
/
Jan 2026
¥3.7B
=
119
Current
¥440.5B
/
Dec 2026
¥12.4B
=
35.6
Forward
¥440.5B
/
Dec 2027
¥15.4B
=
28.6
Forward
¥440.5B
/
Dec 2028
¥18.4B
=
23.9
Forward

Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.

Peer Comparison

All Countries
Close

Market Distribution

Higher than 96% of companies in Japan
Percentile
96th
Based on 5 185 companies
96th percentile
119
Low
0 — 13.1
Typical Range
13.1 — 23
High
23 —
Distribution Statistics
Japan
Min 0
30th Percentile 13.1
Median 17
70th Percentile 23
Max 7 956 708

Kobayashi Pharmaceutical Co Ltd
Glance View

Market Cap
435.2B JPY
Industry
Consumer products

In the bustling landscape of Japanese business, Kobayashi Pharmaceutical Co., Ltd. stands as an epitome of innovation and tradition. Founded in 1886, this company, steeped in history, has consistently demonstrated a knack for transforming simple consumer needs into thriving business opportunities. Core to its operations is the development, manufacturing, and marketing of consumer healthcare products that subtly blend pharmaceutical expertise with daily convenience. This approach has allowed Kobayashi Pharmaceutical to carve out a distinctive niche, particularly in over-the-counter (OTC) health and personal care products. The company's vast array of products is remarkably diverse, ranging from cooling gel sheets for fevers to herbal medicinal drinks, each crafted with an understanding of consumer pain points and a commitment to well-being. What sets Kobayashi apart in the competitive market is its strategic focus on niche products that serve unmet needs. This laser-sharp business model does more than just bolster its domestic market; it drives its global expansion into key markets in Asia, North America, and Europe. The company's profitability hinges not just on innovation but also on its agile response to the shifting preferences of health-conscious consumers. Driven by a mission to deliver "small but valuable products," Kobayashi’s nimble approach, coupled with an impressive R&D focus, ensures that it remains at the forefront of both consumer satisfaction and shareholder value. Much like a well-crafted Japanese garden, every part of Kobayashi's operation is meticulously designed to function harmoniously, making it a standout player in the global consumer healthcare industry.

Intrinsic Value
5 270.32 JPY
Overvaluation 10%
Intrinsic Value
Price ¥5 854
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett